The Drosophila hep pathway mediates Lrrk2-induced neurodegeneration
- 1 August 2018
- journal article
- research article
- Published by Canadian Science Publishing in Biochemistry and Cell Biology
- Vol. 96 (4) , 441-449
Abstract
Although the pathogenesis of Parkinson’s disease (PD) remains unclear, mutations in leucine-rich repeat kinase 2 (Lrrk2) are among the major causes of familial PD. Most of these mutations disrupt Lrrk2 kinase and (or) GTPase domain function, resulting in neuronal degeneration. However, the signal pathways underlying Lrrk2-induced neuronal degeneration are not fully understood. There is an expanding body of evidence that suggests a link between Lrrk2 function and MAP kinase (MAPK) cascades. To further investigate this link in vivo, genetic RNAi screens of the MAPK pathways were performed in a Drosophila model to identify genetic modifier(s) that can suppress G2019S-Lrrk2-induced PD-like phenotypes. The results revealed that the knockdown of hemipterous (hep, or JNKK) increased fly survival time, improved locomotor function, and reduced loss of dopaminergic neurons in G2019S-Lrrk2 transgenic flies. Expression of the dominant-negative allele of JNK (JNK-DN), a kinase that is downstream of hep in G2019S-Lrrk2 transgenic flies, elicited a similar effect. Moreover, treatment with the JNK inhibitor SP600125 partially reversed the G2019S-Lrrk2-induced loss of dopaminergic neurons. These results indicate that the hep pathway plays an important role in Lrrk2-linked Parkinsonism in flies. These studies provide new insights into the molecular mechanisms underlying Lrrk2-linked PD pathogenesis and aid in identifying potential therapeutic targets.Keywords
This publication has 43 references indexed in Scilit:
- Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease modelsHuman Molecular Genetics, 2011
- Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's diseaseNature Medicine, 2010
- LRRK2 and the Stress Response: Interaction with MKKs and JNK-Interacting ProteinsNeurodegenerative Diseases, 2010
- The Parkinson's Disease Associated LRRK2 Exhibits Weaker In Vitro Phosphorylation of 4E-BP Compared to AutophosphorylationPLOS ONE, 2010
- Parkin Protects against LRRK2 G2019S Mutant-Induced Dopaminergic Neurodegeneration in DrosophilaJournal of Neuroscience, 2009
- CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicityProceedings of the National Academy of Sciences, 2009
- JNK2 and JNK3 combined are essential for apoptosis in dopamine neurons of the substantia nigra, but are not required for axon degenerationJournal of Neurochemistry, 2008
- A Drosophila model for LRRK2 -linked parkinsonismProceedings of the National Academy of Sciences, 2008
- A genome-wide transgenic RNAi library for conditional gene inactivation in DrosophilaNature, 2007
- Inhibition of mitogen-activated protein kinase and stimulation of Akt kinase signaling pathways: Two approaches with therapeutic potential in the treatment of neurodegenerative diseasePharmacology & Therapeutics, 2007